托珠单抗对类风湿关节炎患者疗效、免疫球蛋白及辅助性T细胞水平的影响

杜勤; 徐红娣

doi:10.3969/j.issn.1006-0111.201905023

托珠单抗对类风湿关节炎患者疗效、免疫球蛋白及辅助性T细胞水平的影响

doi: 10.3969/j.issn.1006-0111.201905023

杜勤,
徐红娣

浙江省青春医院内科, 浙江杭州 310000

Effects of tocilizumab on the efficacy, immunoglobulin and helper T cells in patients with rheumatoid arthritis

DU Qin,
XU Hongdi

Internal Medicine Department, Zhejiang Youth Hospital, Hangzhou 310000, China

摘要: 目的观察托珠单抗对类风湿关节炎（RA）患者的疗效，以及对患者免疫球蛋白、辅助性T细胞水平的影响。方法选择本院收治的RA患者90例，随机分为对照组与观察组，每组45例。对照组患者接受英夫利西单抗联合甲氨蝶呤治疗方案，观察组患者接受托珠单抗联合甲氨蝶呤治疗方案。两组患者均连续治疗6个月。比较两组患者治疗后的临床疗效；分别检测两组患者治疗前后血清中免疫球蛋白、T辅助细胞-1（T helper1，Th1）以及调节性T细胞（T Regulatory，Treg）的水平。结果治疗后，两组患者晨僵、关节压痛及关节肿胀情况均有所好转，且观察组患者的上述症状情况好转程度明显优于对照组（P<0.05）。两组患者血清中IgG及Th1细胞水平均显著降低，且观察组患者血清中2种细胞水平显著低于对照组（P<0.05）；而两组患者Treg细胞水平均有明显升高，且观察组Treg水平显著高于对照组（P<0.05）。结论托珠单抗可有效改善RA患者临床症状，改善患者免疫功能紊乱，具有较好的临床疗效。
- 托珠单抗 /
- 类风湿关节炎 /
- 免疫蛋白 /
- T辅助细胞 /
- 调节性T细胞
Abstract: Objective To observe the effects of tocilizumab on the efficacy, immunoglobulin and helper T cells in patients with rheumatoid arthritis. Methods 90 patients with rheumatoid arthritis in our hospital were randomly divided into control group and observation group, 45 cases in each group. The patients in the control group were treated with infliximab and methotrexate. The patients in the observation group were treated with tocilizumab and methotrexate. The patients in the two groups were both treated for 6 months. The clinical efficacy of the two groups was compared after treatment. Before and after treatment, the serum levels of immunoglobulin, Th-1 and Treg of patients in two groups were measured. Results The results showed that after treatment, the situation of morning stiffness, joint pressure pain and joint swelling of the patients in the two groups were improved, and the improvement of morning stiffness, joint pressure pain and joint swelling in the observation group was greater (P<0.05). The levels of IgG and Th1 cells in the serum of patients in the two groups significantly decreased, and the levels of IgG and Th1 cells in the serum of the patients in the observation group were significantly lower than that of the control group (P<0.05). The serum level of Treg cells in the serum of patients in the two groups increased significantly, and the level of Treg in the serum of patients in the observation group was significantly higher than that in the control group (P<0.05). Conclusion Topazumab could effectively improve the clinical symptoms of patients with rheumatoid arthritis, and improve the immune dysfunction of the patients with better clinical efficacy.
- tocilizumab /
- rheumatoid arthritis /
- immunoglobulin /
- Th1 /
- Treg

[1]	ZABOTTI A, MANDL P, ZAMPOGNA G, et al. One year in review 2018: ultrasonography in rheumatoid arthritis and psoriatic arthritis[J]. Clin Exp Rheumatol,2018,36(4):519-525
[2]	COHEN S B, ALTEN R, KAMEDA H, et al. A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy[J]. Arthritis Res Ther,2018,20(1):155
[3]	ALLEVA J M, DIEDRICHS P C, HALLIWELL E, et al. More than my RA: A randomized trial investigating body image improvement among women with rheumatoid arthritis using a functionality-focused intervention program[J]. J Consult Clin Psychol,2018,86(8):666-676
[4]	胡晓敏, 宗英, 余珊珊, 等. 类风湿关节炎治疗药物的研发进展及趋势[J]. 中国新药杂志, 2017, 26(1):36-43
[5]	钱仲华, 孔小阳, 钱唯韵, 等. 舒适护理在老年类风湿关节炎患者中的应用[J]. 实用老年医学, 2016, 30(1):85-86
[6]	张挺, 周艳, 李永吉, 等. 托珠单抗与英夫利西单抗在类风湿关节炎治疗中的疗效评价[J]. 全科医学临床与教育, 2017, 15(3):255-258
[7]	TANAKA Y, KAMEDA H, SAITO K, et al. Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study[J]. Arthritis Res Ther,2018,20(1):151
[8]	ARNETT F C, EDWORTHY S M, BLOCH D A, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthritis Rheum,1988,31(3):315-324
[9]	饶莉, 石哲群, 杨静. 痹祺胶囊联合托珠单抗治疗类风湿性关节炎的临床疗效观察[J]. 中药材, 2015, 38(4):866-868
[10]	OTSUKA Y, KIYOHARA C, KASHIWADO Y, et al. Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study[J]. PLoS One,2018,13(4):e0196368
[11]	毕东敏, 魏建芬, 张万壮, 等. 麝香乌龙丸对中医不同证型类风湿关节炎血清MIF、ICAM-1、VCAM-1表达的影响[J]. 湖南师范大学学报(医学版), 2016, 13(4):129-132
[12]	CHOY E, CAPORALI R, XAVIER R, et al. Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries[J]. Rheumatology (Oxford),2018,57(6):1129
[13]	杨洋, 李伟杰, 刘金玉, 等. 托珠单抗单用与联合甲氨蝶呤治疗类风湿性关节炎疗效和安全性比较的Meta分析[J]. 中国药师, 2017, 20(5):854-859
[14]	陈乐锋, 马剑达, 韦秀宁, 等. 托珠单抗联合治疗对难治性类风湿关节炎患者病情活动及心理状态的疗效观察[J]. 中华风湿病学杂志, 2015, 19(2):115-118
[15]	肖雪野. 抗CCP抗体、补体及免疫球蛋白在类风湿性关节炎病理过程中的变化及临床意义[J]. 海南医学院学报, 2017, 23(4):514-517
[16]	刘军慧, 邹蕾, 罗妍. TCZ联合IMD治疗RRA的疗效和对ESR、CRP、IgG水平的影响[J]. 西南国防医药, 2018, 28(5):406-409
[17]	罗小红, 周娟, 洪学志, 等. 青蒿治疗难治性类风湿关节炎患者的疗效及对TH17/Treg细胞因子的影响[J]. 中国医院药学杂志, 2017, 37(24):2451-2455

[1]	桂明珠, 李静, 李志玲. 儿童伏立康唑的血药浓度与CYP2C19、CYP2C9和CYP3A5基因多态性的相关性研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402020
[2]	段禹, 刘爱军. 活血化瘀法治疗血管性痴呆的研究进展 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202408045
[3]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[4]	王耀振, 徐灿, 吕顺莉, 田泾, 张东炜. 钾离子竞争性酸阻滞剂的药学特征研究进展 . 药学实践与服务, 2024, 42(7): 278-284. doi: 10.12206/j.issn.2097-2024.202306040
[5]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[6]	徐璐璐, 刘爱军. 丹参白术方“异病同治”冠心病、血管性痴呆、特发性膜性肾病的网络药理学作用机制研究 . 药学实践与服务, 2024, 42(12): 1-8. doi: 10.12206/j.issn.2097-2024.202312027
[7]	张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英. 二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
[8]	顾佳钰, 胡馨儿, 王晓飞, 张颖, 张海, 曹岩. 侧流免疫层析定量检测方法的研究进展 . 药学实践与服务, 2024, 42(7): 273-277, 284. doi: 10.12206/j.issn.2097-2024.202307037
[9]	马兹芬, 许维恒, 金煜翔, 薛磊. 食管癌的靶向治疗与免疫治疗研究进展 . 药学实践与服务, 2024, 42(6): 231-237. doi: 10.12206/j.issn.2097-2024.202306008
[10]	冯志惠, 邓仪卿, 叶冰, 安培, 张宏, 张海军. 雀梅藤石油醚提取物诱导三阴性乳腺癌细胞凋亡的实验研究 . 药学实践与服务, 2024, 42(6): 253-259. doi: 10.12206/j.issn.2097-2024.202311055
[11]	刘汝雄, 杨万镇, 涂杰, 盛春泉. 铁死亡调控蛋白GPX4的小分子抑制剂研究进展 . 药学实践与服务, 2024, 42(9): 375-378. doi: 10.12206/j.issn.2097-2024.202312075
[12]	修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星. 全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 291-296. doi: 10.12206/j.issn.2097-2024.202312054
[13]	姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量. 巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
[14]	杨媛媛, 安晓强, 许佳捷, 江键, 梁媛媛. 正极性驻极体联合5-氟尿嘧啶对瘢痕成纤维细胞生长抑制的协同作用 . 药学实践与服务, 2024, 42(6): 244-247. doi: 10.12206/j.issn.2097-2024.202310027
[15]	冯婷婷, 张景翔, 王彦, 许维恒, 张俊平. ANXA3基因及蛋白的研究进展 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202309023
[16]	石晓萍, 吕迁洲, 李晓宇, 许青. 泊沙康唑对比伏立康唑经验治疗或诊断驱动治疗免疫功能低下患者侵袭性霉菌病的成本-效果分析 . 药学实践与服务, 2024, 42(12): 512-519. doi: 10.12206/j.issn.2097-2024.202401050
[17]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
[18]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[19]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[20]	唐淑慧, 凤美娟, 薛智霞, 鲁桂华. 帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029

点击查看大图

计量

文章访问数: 5861
HTML全文浏览量: 722
PDF下载量: 3086
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

托珠单抗对类风湿关节炎患者疗效、免疫球蛋白及辅助性T细胞水平的影响

doi: 10.3969/j.issn.1006-0111.201905023

Effects of tocilizumab on the efficacy, immunoglobulin and helper T cells in patients with rheumatoid arthritis

计量

托珠单抗对类风湿关节炎患者疗效、免疫球蛋白及辅助性T细胞水平的影响

doi: 10.3969/j.issn.1006-0111.201905023

浙江省青春医院内科, 浙江杭州 310000

English Abstract

Effects of tocilizumab on the efficacy, immunoglobulin and helper T cells in patients with rheumatoid arthritis

Internal Medicine Department, Zhejiang Youth Hospital, Hangzhou 310000, China

全文HTML

目录

留言板

托珠单抗对类风湿关节炎患者疗效、免疫球蛋白及辅助性T细胞水平的影响

doi: 10.3969/j.issn.1006-0111.201905023

Effects of tocilizumab on the efficacy, immunoglobulin and helper T cells in patients with rheumatoid arthritis

计量

出版历程

托珠单抗对类风湿关节炎患者疗效、免疫球蛋白及辅助性T细胞水平的影响

doi: 10.3969/j.issn.1006-0111.201905023

浙江省青春医院内科, 浙江 杭州 310000

English Abstract

Effects of tocilizumab on the efficacy, immunoglobulin and helper T cells in patients with rheumatoid arthritis

Internal Medicine Department, Zhejiang Youth Hospital, Hangzhou 310000, China

全文HTML

目录

浙江省青春医院内科, 浙江杭州 310000